A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints by Standaert, D.G, Fernandez, H.H, Odin, P, Hauser, R.A, Espay, A.J, Steiger, M, Chouinard, S, Suchowersky, O, Yakupov, E, Merikle, E.P, Robieson, W.Z, Chatamra, K, Benesh, J

Get full text